(HealthDay)—This flu season looks like it could be worse than usual, due to an aggressive strain of influenza virus that might flout the protection provided by this year's vaccine, U.S. health officials warned Thursday.
Dec 4, 2014
0
0
(HealthDay)—This year's flu season is off to a slow but detectable start. And it appears to be a typical one that's likely to peak in January or February, a leading U.S. health official says.
Nov 21, 2014
0
0
An international team of researchers has shown that it may be possible to improve the effectiveness of the seasonal flu vaccine by 'pre-empting' the evolution of the influenza virus.
Nov 20, 2014
0
0
Ebola virus has captured the attention of the world since the outbreak in West Africa began months ago, so far claiming nearly 5,000 lives.
Nov 7, 2014
1
0
A team of scientists, led by researchers at The Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-2014 influenza season. ...
Oct 21, 2014
0
0
A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system.
May 14, 2014
0
0
In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers believe ...
Mar 2, 2014
0
0
Researchers at Columbia University and the University of Cologne have created a new model to successfully predict the evolution of the influenza virus from one year to the next. This advance in our understanding of influenza ...
Feb 26, 2014
0
5
The flu is hitting young and middle aged people in the United States particularly hard this season, as a tough flu strain re-emerged and too few people were vaccinated, health authorities said Thursday.
Feb 20, 2014
0
0
Perth researchers developing a new whooping cough vaccine have described immune responses produced in pre-clinical testing with the new vaccine as 'exquisite'.
Jan 28, 2014
0
0
